EGFR and COVID-19: In mild COVID-19 cases (hospitalized for oxygen therapy only), we observed elevated activity of epithelial growth factor receptor (EGFR) and metalloproteinase (MMP9), along with increased expression of survival factors like Bax and Bcl2, which can be related to endocrine resistance through several mechanisms.